Insulet Corp. (PODD)
158.35
+4.18
(+2.71%)
USD |
NASDAQ |
May 12, 16:00
157.00
-1.35
(-0.85%)
After-Hours: 20:00
Insulet Free Cash Flow : 387.80M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.475B |
| Abbott Laboratories | 7.378B |
| Intuitive Surgical, Inc. | 2.834B |
| Stryker Corp. | 4.571B |
| Tandem Diabetes Care, Inc. | -3.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 113.80M |
| Cash from Investing (Quarterly) | -27.70M |
| Cash from Financing (Quarterly) | -319.90M |
| Free Cash Flow Per Share (Quarterly) | 1.225 |
| Free Cash Flow to Equity (Quarterly) | 139.80M |
| Free Cash Flow to Firm (Quarterly) | 97.85M |
| Free Cash Flow Yield | 3.47% |